Nektar (NKTR) reports agreement to sell Cimzia(R) and Mircera(R) royalties to Royalty Pharma for $124M
Tweet Send to a Friend
Up)
Nektar (Nasdaq: NKTR) reports agreement to sell Cimzia(R) and Mircera(R) royalties to Royalty Pharma for $124M
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: ViroPharma (VPHM) on the Move Following Takeover Chatter - Reuters
- Tetra Tech (TTEK) to resume trading at 5:00pm ET
- Walter Energy (WLT) Trading Paused; Pulls $1.55B Debt Refi
Create E-mail Alert Related Categories
Mergers and Acquisitions, Trading Halts
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
